August 10, 2004Circulation
Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy
Why the study?
Does reducing albuminuria afford cardiovascular protection in patients with type 2 diabetic nephropathy?
Structured PICO
Does reducing albuminuria afford cardiovascular protection in patients with type 2 diabetic nephropathy?
P
Population
Patients with type 2 diabetic nephropathy
I
Intervention
Reducing albuminuria in the first 6 months
O
Outcome
Cardiovascular protection
Albuminuria reduction is highlighted as a therapeutic target for cardiovascular protection in type 2 diabetic nephropathy.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
May support albuminuria reduction as CV target in T2DM nephropathy; leaves open confirmation by RCTs.
Cite This Study
Zeeuw et al. (2004) studied this question.